Companies / Genoskin
Genoskin
Salem, Massachusetts, United States
Genoskin keeps real, donor-consented human skin alive and immunocompetent for up to 10 days in culture, so teams can generate reliable human data before clinical trials.
Genoskin, based in Salem, Massachusetts, United States, has 1 investor on file, among them BNP Paribas Développement. Its latest round on record is Series A, 16 Sept 2025. Its site was last checked 7 Nov 2026: site answers.
Funding
1 round on recordRound sizes and total raised are on Fundup AI, our sister product for funding data.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC |
More from BNP Paribas Développement
30 companies on its checked portfolioIts portfolio leans to Fintech (26%), Education (19%), Industrial & Manufacturing (11%).
See BNP Paribas Développement's full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Genoskin and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when BNP Paribas Développement adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/genoskin.com/investors
# also
GET /v1/companies/genoskin.com
GET /v1/companies/genoskin.com/news